Mydecine Innovations Group Inc (MYCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2014 | 08-2014 | 12-2013 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 87 | 104 | 6 |
| Receivables | 2 | N/A | 0 |
| Other current assets | 11 | 0 | 0 |
| TOTAL | $107 | $104 | $6 |
| Non-Current Assets | |||
| PPE Net | 1,255 | N/A | 1,280 |
| Other Non-Current Assets | 650 | 0 | 650 |
| TOTAL | $1,905 | $0 | $1,930 |
| Total Assets | $2,013 | $104 | $1,936 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 18 | 124 | 17 |
| Accounts payable and accrued liabilities | 20 | N/A | 6 |
| Accrued Expenses | 342 | 0 | 20 |
| Other current liabilities | 7 | N/A | N/A |
| TOTAL | $387 | $124 | $43 |
| Non-Current Liabilities | |||
| Long Term Debt | 1,533 | N/A | 951 |
| Other Non-Current Liabilities | 0 | 0 | 7 |
| TOTAL | $1,533 | $0 | $958 |
| Total Liabilities | $1,920 | $124 | $1,001 |
| Shareholders' Equity | |||
| Retained earnings | -2,371 | -26 | -1,145 |
| Other shareholders' equity | 110 | 0 | 0 |
| TOTAL | $93 | $-21 | $935 |
| Total Liabilities And Equity | $2,013 | $104 | $1,936 |